IRIS
CENCINI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.526
EU - Europa 2.938
AS - Asia 1.683
SA - Sud America 308
AF - Africa 91
OC - Oceania 4
Totale 8.550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.473
RU - Federazione Russa 732
GB - Regno Unito 669
CN - Cina 519
SG - Singapore 496
IE - Irlanda 374
IT - Italia 350
BR - Brasile 260
SE - Svezia 200
VN - Vietnam 188
FR - Francia 142
UA - Ucraina 128
HK - Hong Kong 122
DE - Germania 114
BD - Bangladesh 112
FI - Finlandia 105
KR - Corea 54
IN - India 51
ZA - Sudafrica 40
TR - Turchia 32
CA - Canada 28
AR - Argentina 24
JP - Giappone 21
PL - Polonia 21
IQ - Iraq 19
NL - Olanda 19
MX - Messico 17
AT - Austria 16
BE - Belgio 14
KE - Kenya 14
CZ - Repubblica Ceca 12
NG - Nigeria 11
SA - Arabia Saudita 11
ES - Italia 10
PK - Pakistan 8
CI - Costa d'Avorio 7
IR - Iran 7
EC - Ecuador 6
MA - Marocco 6
SK - Slovacchia (Repubblica Slovacca) 6
UZ - Uzbekistan 6
CO - Colombia 5
EG - Egitto 5
PH - Filippine 5
TN - Tunisia 5
AU - Australia 4
ID - Indonesia 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
JO - Giordania 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.550
Salva come PNG Salva come JPEG
Città #
Southend 594
Fairfield 389
Dublin 372
Dallas 340
Singapore 312
Ashburn 285
Moscow 216
Santa Clara 188
Chandler 170
Woodbridge 170
San Jose 149
Houston 148
Beijing 147
Seattle 140
Ann Arbor 135
Wilmington 129
Cambridge 120
Hong Kong 118
Jacksonville 107
Hefei 97
Siena 77
Princeton 63
Dearborn 60
The Dalles 60
Los Angeles 54
Seoul 54
Ho Chi Minh City 50
Hanoi 48
Lauterbourg 47
Nanjing 44
Munich 42
New York 39
Johannesburg 37
Helsinki 35
Council Bluffs 32
Turku 32
Milan 31
Izmir 28
Lappeenranta 27
Menlo Park 25
Florence 24
Boardman 22
San Mateo 22
São Paulo 22
Orem 21
Buffalo 18
Redondo Beach 18
Dong Ket 16
Brussels 14
Chicago 14
Chennai 13
London 13
Rome 13
Bengaluru 12
Frankfurt am Main 11
Guangzhou 11
Nanchang 11
San Diego 11
Tianjin 11
Warsaw 11
Bologna 10
Columbus 10
Haiphong 10
Jinan 10
San Francisco 10
Shanghai 10
Toronto 10
Atlanta 9
Da Nang 9
Denver 9
Kunming 9
Montreal 9
Nairobi 9
Rio de Janeiro 9
Shenyang 9
Tokyo 9
Vienna 9
Abuja 8
Baghdad 8
Belo Horizonte 8
Brooklyn 8
Abidjan 7
Changsha 7
Portsmouth 7
Stockholm 7
Brno 6
Hebei 6
Jiaxing 6
Poplar 6
Amsterdam 5
Boston 5
Maceió 5
Memphis 5
Mexico City 5
New Delhi 5
Nuremberg 5
Phoenix 5
Tashkent 5
Cagliari 4
Dhaka 4
Totale 5.816
Salva come PNG Salva come JPEG
Nome #
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 435
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 293
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 276
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 251
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma 238
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large B-cell lymphoma 236
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 235
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 220
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab 218
New perspectives for patients with primary CNS lymphoma 216
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 216
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 216
Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma 212
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma 212
Impressive and durable response in a case of multiple relapsed mantle cell lymphoma treated with bortezomib and rituximab 211
Primary Nasopharyngeal Hodgkin Lymphoma 205
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas 196
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience 194
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant 191
Prognostic significance of lymphocyte/monocyte count and neutrophil/lymphocyte count in peripheral T cell lymphoma 190
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma 189
Long term remission in a case of Plasmablastic lymphoma treated with COMP (Cyclophosphamide, Liposomal Doxorubicin, Vincristine, Prednisone) and Bortezomib 188
Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma 182
Therapeutic use of Brentuximab Vedotin In Cd30+ hematologic malignancies 179
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review 178
Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma 175
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma 175
Prognostic role of m2 Tumour-Associated macrophages in lymphoproliferative disorders 173
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 169
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma 149
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 147
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 141
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 141
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 140
How to manage early-stage follicular lymphoma 139
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 132
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications 132
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi 130
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series 130
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma 128
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? 128
Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract 121
Survival outcomes of patients with mantle cell lymphoma: a retrospective, 15-Year, real-life study 111
Development and implementation of the International AIDA Network Castleman’s disease registry 104
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 98
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) 97
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 83
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi 77
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone 67
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network) 66
Totale 8.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.591
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/2022476 29 47 34 47 31 27 15 15 24 48 54 105
2022/2023636 34 62 85 73 77 130 17 43 63 6 24 22
2023/2024578 20 15 35 58 14 125 220 10 8 32 3 38
2024/20251.278 45 71 169 50 157 73 20 65 59 85 155 329
2025/20263.118 242 384 291 446 680 128 331 90 91 147 123 165
Totale 8.730